Realbotix Investor Webinar: Commercial Traction, Nasdaq Path, and What Comes Next | April 23, 2026

Andrew Kiguel's takeaways

• Top takeaway Kiguel says the company's top near-term milestone is completing the announced NASDAQ transaction, which he argues brings capital and a US listing without dilution while XBOT holders keep primary ownership — potentially the first pure-play humanoid robotics company on NASDAQ.
• He argues Realbotix is not competing with Tesla or Figure AI: their walking robots run about 30 minutes per charge, while his wheeled, wall-pluggable robots last around 10 hours and can safely serve public-facing roles in hotels, schools, and senior care.
• He points to Ericsson as early commercial traction: a CES rental programmed as a 6G expert for the Verizon head office turned into robot orders and, as of the webinar, delivery of the first Vinci vision robot.
• He says production should reach the hundreds of robots by the end of 2026 and thousands by the end of 2027, from a new US office that was under construction at the time of the webinar.
• He sees healthcare and education as the key next markets — companionship for lonely or elderly people, clinical-trial monitoring that he says removes human bias, and AI tutoring at a couple of dollars a month — with the vision-enabled Ask Aria app relaunching in May as a free trial before a paid tier.